{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:10:07Z","timestamp":1746335407728,"version":"3.40.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is a novel acute respiratory infectious disease that can lead to multiple-organ dysfunction in patients with severe disease. However, there is a lack of effective antiviral drugs for COVID-19. Herein, we investigated the efficacy and safety of convalescent plasma (CP) therapy for treating severe COVID-19 in an attempt to explore new therapeutic methods.<\/jats:p>\n          <jats:p>The clinical data of 3 imported patients with severe COVID-19 who underwent treatment with CP and who were quarantined and treated in a designated COVID-19 hospital from March 2020 to April 2020 were collected and analyzed.<\/jats:p>\n          <jats:p>The 3 patients, including a 57-year-old male, 65-year-old female, and 59-year-old female, were clinically classified as having severe COVID-19. The main underlying diseases included hypertension, diabetes, sequelae of cerebral infarction, and postoperative thyroid adenoma. The common symptoms included cough, fever, and shortness of breath. All patients received antiviral drugs and other supportive treatments. Additionally, CP treatment was administered. At 48 to 72 hours after the CP transfusion, all 3 of the patients exhibited an improvement and alleviation of symptoms, an elevated arterial oxygen saturation, and decreased C-reactive protein and interleukin-6 levels. The counts of the total lymphocytes and T lymphocytes (CD3+) and their subsets (CD4 + and CD8+) were also obviously increased. Repeated chest computed tomography also revealed obvious absorption of the lesions in the bilateral lungs. Only 1 patient had a mild allergic reaction during the CP infusion, but no severe adverse reactions were observed.<\/jats:p>\n          <jats:p>The early treatment with CP in patients with severe COVID-19 can rapidly improve the condition of the patients, and CP therapy is generally effective and safe.<\/jats:p>","DOI":"10.1097\/md.0000000000029912","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:06:24Z","timestamp":1660053984000},"page":"e29912","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Convalescent plasma therapy for patients with severe COVID-19: A case series study"],"prefix":"10.1097","volume":"101","author":[{"given":"Jinbao","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, People\u2019s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, People\u2019s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fuzhou Pulmonary Hospital of Fujian, Educational Hospital of Fujian Medical University, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, People\u2019s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"473","article-title":"Chinese medical association respiratory branch, Chinese medical doctor association respiratory physician branch. Expert advice for COVID-19 prevention and control","volume":"43","author":"Qu","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1182\/blood.2020007714","article-title":"Convalescent plasma to treat COVID-19","volume":"136","author":"Bloch","year":"2020","journal-title":"Blood"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.18632\/aging.103102","article-title":"Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.2020.10218","article-title":"A randomized trial of convalescent plasma for COVID-19-potentially hopeful signals","volume":"324","author":"Casadevall","year":"2020","journal-title":"JAMA"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa2031304","article-title":"A randomized trial of convalescent plasma in Covid-19 severe pneumonia","volume":"384","author":"Simonovich","year":"2021","journal-title":"N Engl J Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"R12-20250504","first-page":"414","article-title":"Diagnosis and treatment program of novel coronavirus infection disease in military medical team for assisting Hubei (Trial version 2)","volume":"43","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40121-020-00341-2","article-title":"Factors associated with good patient outcomes following convalescent plasma in COVID-19: a prospective phase II clinical trial","volume":"9","author":"Ibrahim","year":"2020","journal-title":"Infect Dis Ther"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.2020006964","article-title":"Use of convalescent plasma in hospitalized patients with COVID-19: case series","volume":"136","author":"Hegerova","year":"2020","journal-title":"Blood"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"102554","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: possible mechanisms of action","author":"Rojas","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R17-20250504","first-page":"203","article-title":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia.","volume":"43","author":"Chen","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2020007079","article-title":"Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion","volume":"136","author":"Xia","year":"2020","journal-title":"Blood"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-020-1088-9","article-title":"Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study","volume":"26","author":"Liu","year":"2020","journal-title":"Nat Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1172\/JCI140200","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5000 patients","volume":"130","author":"Joyner","year":"2020","journal-title":"J Clin Invest"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.12688\/f1000research.36396.2","article-title":"Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis","volume":"10","author":"Wardhani","year":"2021","journal-title":"F1000Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:28:40Z","timestamp":1746332920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":21,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029912","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}